Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
[3][4] For practitioners evaluating Retatrutide alternatives for weight loss, the primary approved options are Tirzepatide, an FDA-approved dual GLP-1/GIP receptor agonist (Mounjaro/Zepbound), and Semaglutide, an FDA-approved GLP-1 receptor agonist (Ozempic/Wegovy)
The development of eosinophils requires IL-5
Other GLP-1 medications are FDA-approved to treat obesity
Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice
US$ 22.62
US$ 29.27
US$ 22.94
